US4099012A
(en)
|
1975-08-28 |
1978-07-04 |
Ciba-Geigy Corporation |
2-pyrazolyl-benzophenones
|
FR2450833A1
(fr)
|
1979-02-07 |
1980-10-03 |
Hoffmann La Roche |
Derives de benzazepine
|
US4481142A
(en)
|
1979-02-07 |
1984-11-06 |
Hoffmann-La Roche Inc. |
Pyrimido-2-benzazepines
|
US4469633A
(en)
|
1980-05-16 |
1984-09-04 |
Hoffmann-La Roche Inc. |
N-oxides of 5-oxo-1-phenyl-2-benzazepines
|
EP0273697A3
(en)
|
1986-12-30 |
1989-11-29 |
Merck & Co. Inc. |
2-benzazepines with 5- and 6- membered heterocyclic rings
|
US5166151A
(en)
|
1988-03-25 |
1992-11-24 |
Merck & Co., Inc. |
2-Benzazepines with 5- and 6-membered heterocyclic rings, compositions and medical methods of use thereof
|
US5721356A
(en)
|
1989-09-15 |
1998-02-24 |
Gensia, Inc. |
Orally active adenosine kinase inhibitors
|
US5210082A
(en)
|
1991-05-16 |
1993-05-11 |
Merck & Co., Inc. |
2-benzazepines with 5- and 6-membered heterocyclic rings to treat pain and anxiety disorders
|
IL108523A0
(en)
|
1993-02-03 |
1994-05-30 |
Gensia Inc |
Pharmaceutical compositions containing adenosine kinase inhibitors for preventing or treating conditions involving inflammatory responses and pain
|
US5747487A
(en)
|
1993-07-29 |
1998-05-05 |
American Cyanamid Company |
Tricyclic benzazepine vasopressin antagonists
|
AU711592B2
(en)
|
1995-04-03 |
1999-10-14 |
Novartis Ag |
Pyrazole derivatives and processes for the preparation thereof
|
US5593997A
(en)
|
1995-05-23 |
1997-01-14 |
Pfizer Inc. |
4-aminopyrazolo(3-,4-D)pyrimidine and 4-aminopyrazolo-(3,4-D)pyridine tyrosine kinase inhibitors
|
US6403599B1
(en)
|
1995-11-08 |
2002-06-11 |
Pfizer Inc |
Corticotropin releasing factor antagonists
|
GB9521987D0
(en)
|
1995-10-26 |
1996-01-03 |
Ludwig Inst Cancer Res |
Phosphoinositide 3-kinase modulators
|
GB9523675D0
(en)
|
1995-11-20 |
1996-01-24 |
Celltech Therapeutics Ltd |
Chemical compounds
|
CA2247453A1
(en)
|
1996-03-08 |
1997-09-12 |
Joseph James Lewis |
Azolobenzazepine derivatives as neurologically active agents
|
DE69732780T2
(de)
|
1996-10-02 |
2006-04-06 |
Novartis Ag |
Pyrimiderivate und verfahren zu ihrer herstellung
|
US6057329A
(en)
|
1996-12-23 |
2000-05-02 |
Celltech Therapeutics Limited |
Fused polycyclic 2-aminopyrimidine derivatives
|
WO1998035048A2
(en)
|
1997-02-07 |
1998-08-13 |
Princeton University |
Engineered protein kinases which can utilize modified nucleotide triphosphate substrates
|
US7863444B2
(en)
|
1997-03-19 |
2011-01-04 |
Abbott Laboratories |
4-aminopyrrolopyrimidines as kinase inhibitors
|
GB9713087D0
(en)
|
1997-06-20 |
1997-08-27 |
Celltech Therapeutics Ltd |
Chemical compounds
|
AU744636B2
(en)
|
1997-09-29 |
2002-02-28 |
Meiji Seika Pharma Co., Ltd. |
Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic
|
US6251689B1
(en)
|
1998-05-14 |
2001-06-26 |
Telik, Inc. |
Methods for the solid phase synthesis of combinatorial libraries of benzimidazoles benzoxazoles benzothiazoles and derivatives thereof
|
BR9911612A
(pt)
|
1998-06-02 |
2001-02-06 |
Osi Pharm Inc |
Composições de pirrolo[2,3d]pirimidina e seus usos
|
US6277844B1
(en)
|
1998-09-14 |
2001-08-21 |
Sydney Spector |
Compound for selective treatment of malignant cells by inhibiting cell cycle progression, decreasing Bcl2, and increasing apoptosis
|
TR200101359T2
(tr)
|
1998-11-16 |
2001-11-21 |
Basf Aktiengesellschaft |
3-[Benz(Ok/Otı)Azol-7-İl]-1H-Pirimidin-2,4-Dionlar
|
EP1140938B1
(en)
|
1999-01-11 |
2003-08-27 |
Princeton University |
High affinity inhibitors for target validation and uses thereof
|
CZ27399A3
(cs)
|
1999-01-26 |
2000-08-16 |
Ústav Experimentální Botaniky Av Čr |
Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv
|
US6417207B1
(en)
|
1999-05-12 |
2002-07-09 |
Nitromed, Inc. |
Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
|
AU784971B2
(en)
|
1999-08-11 |
2006-08-10 |
Biogen Inc. |
Treatment of patients having non-Hodgkins lymphoma with bone marrow involvement with anti-CD20 antibodies
|
CA2385747A1
(en)
|
1999-09-17 |
2001-03-22 |
Gavin C. Hirst |
Pyrazolopyrimidines as therapeutic agents
|
US6921763B2
(en)
|
1999-09-17 |
2005-07-26 |
Abbott Laboratories |
Pyrazolopyrimidines as therapeutic agents
|
JP2003528141A
(ja)
|
2000-03-24 |
2003-09-24 |
ベーカー ノートン ファーマシューティカルズ インコーポレイテッド |
タキサンに基づく組成物および使用方法
|
DE60120193T2
(de)
|
2000-09-15 |
2007-03-29 |
Vertex Pharmaceuticals Inc., Cambridge |
Pyrazolverbindungen als protein-kinasehemmer
|
ATE528303T1
(de)
|
2000-12-21 |
2011-10-15 |
Vertex Pharma |
Pyrazoleverbindungen als proteinkinasehemmer
|
SI20848A
(sl)
|
2001-03-14 |
2002-10-31 |
Lek, Tovarna Farmacevtskih In Kemijskih Izdelkov, D.D. |
Farmacevtska formulacija, ki vsebuje atorvastatin kalcij
|
MXPA03008560A
(es)
|
2001-03-22 |
2004-06-30 |
Abbot Gmbh & Co Kg |
Pirazolopirimidinas como agentes terapeuticos.
|
US6686352B2
(en)
|
2001-05-18 |
2004-02-03 |
Hoffmann-La Roche Inc. |
Substituted imidazo [1,5-a] pyrimido [5,4-d] [1] benzazepine derivatives
|
WO2003000187A2
(en)
|
2001-06-21 |
2003-01-03 |
Ariad Pharmaceuticals, Inc. |
Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
|
NZ530741A
(en)
|
2001-08-09 |
2006-08-31 |
Actelion Pharmaceuticals Ltd |
Novel benzo-fused heterocycles as endothelin antagonists
|
AU2003225933A1
(en)
|
2002-03-22 |
2003-10-13 |
Cellular Genomics, Inc. |
AN IMPROVED FORMULATION OF CERTAIN PYRAZOLO(3,4-d) PYRIMIDINES AS KINASE MODULATORS
|
US6982253B2
(en)
|
2002-06-05 |
2006-01-03 |
Supergen, Inc. |
Liquid formulation of decitabine and use of the same
|
UA80171C2
(en)
|
2002-12-19 |
2007-08-27 |
Pfizer Prod Inc |
Pyrrolopyrimidine derivatives
|
US7247736B2
(en)
|
2002-12-23 |
2007-07-24 |
4Sc Ag |
Method of identifying inhibitors of DHODH
|
GB0306907D0
(en)
|
2003-03-26 |
2003-04-30 |
Angiogene Pharm Ltd |
Boireductively-activated prodrugs
|
US7429596B2
(en)
|
2003-06-20 |
2008-09-30 |
The Regents Of The University Of California |
1H-pyrrolo [2,3-D] pyrimidine derivatives and methods of use thereof
|
WO2005044181A2
(en)
|
2003-09-09 |
2005-05-19 |
Temple University-Of The Commonwealth System Of Higher Education |
Protection of tissues and cells from cytotoxic effects of ionizing radiation by abl inhibitors
|
CN101906106A
(zh)
|
2003-09-18 |
2010-12-08 |
康福玛医药公司 |
作为hsp90-抑制剂的新的杂环化合物
|
CN1897950A
(zh)
|
2003-10-14 |
2007-01-17 |
惠氏公司 |
稠合芳基和杂芳基衍生物及其使用方法
|
JP2007511596A
(ja)
|
2003-11-17 |
2007-05-10 |
ファイザー・プロダクツ・インク |
癌の治療において有用なピロロピリミジン化合物
|
AR046845A1
(es)
|
2003-11-21 |
2005-12-28 |
Novartis Ag |
Derivados de 1h-imidazo[4,5-c]quinolina para tratamiento de enfermedades dependientes de las proteino-quinasas
|
CA2553724A1
(en)
|
2004-02-03 |
2005-08-18 |
Abbott Laboratories |
Aminobenzoxazoles as therapeutic agents
|
WO2005076987A2
(en)
|
2004-02-10 |
2005-08-25 |
Santarus, Inc. |
Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent
|
MXPA06009462A
(es)
|
2004-02-27 |
2007-03-15 |
Hoffmann La Roche |
Derivados pirazolo heteroaril fusionados.
|
BRPI0508036A
(pt)
|
2004-02-27 |
2007-07-17 |
Hoffmann La Roche |
derivados fundidos de pirazola
|
JP4832426B2
(ja)
|
2004-04-02 |
2011-12-07 |
オーエスアイ・ファーマスーティカルズ・インコーポレーテッド |
6,6−二環置換されたヘテロ二環式タンパク質キナーゼ阻害剤
|
CA2566609C
(en)
|
2004-05-13 |
2012-06-26 |
Icos Corporation |
Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
|
ATE381566T1
(de)
|
2004-05-14 |
2008-01-15 |
Millennium Pharm Inc |
Verbindungen und verfahren zur inhibierung der mitotischen progression durch hemmung von aurorakinase
|
GB0425035D0
(en)
|
2004-11-12 |
2004-12-15 |
Novartis Ag |
Organic compounds
|
US8153630B2
(en)
|
2004-11-17 |
2012-04-10 |
Miikana Therapeutics, Inc. |
Kinase inhibitors
|
US9512125B2
(en)
|
2004-11-19 |
2016-12-06 |
The Regents Of The University Of California |
Substituted pyrazolo[3.4-D] pyrimidines as anti-inflammatory agents
|
EP1836188A1
(en)
|
2004-12-30 |
2007-09-26 |
Astex Therapeutics Limited |
Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinases
|
US7579348B2
(en)
|
2005-02-25 |
2009-08-25 |
Pgxhealth, Llc |
Derivatives of 8-substituted xanthines
|
JP2008538571A
(ja)
|
2005-04-22 |
2008-10-30 |
ワイス |
ジヒドロベンゾフラン誘導体およびその使用
|
EP1919914A2
(en)
|
2005-08-25 |
2008-05-14 |
F.Hoffmann-La Roche Ag |
P38 map kinase inhibitors and methods for using the same
|
MX2008002385A
(es)
|
2005-08-25 |
2008-03-18 |
Hoffmann La Roche |
Inhibidores de proteinas cinasas activads por mitogenos p38 y metodos para utilizarlos.
|
US20070072897A1
(en)
|
2005-09-29 |
2007-03-29 |
Wyeth |
Phenylaminopropanol derivatives and methods of their use
|
BRPI0618622A2
(pt)
|
2005-11-17 |
2011-09-06 |
Osi Pharm Inc |
composto, composição, e, uso de um composto
|
AR057960A1
(es)
|
2005-12-02 |
2007-12-26 |
Osi Pharm Inc |
Inhibidores de proteina quinasa biciclicos
|
WO2007075554A2
(en)
|
2005-12-19 |
2007-07-05 |
Osi Pharmaceuticals, Inc. |
Combination of igfr inhibitor and anti-cancer agent
|
CA2634787C
(en)
|
2005-12-23 |
2014-10-21 |
Smithkline Beecham Corporation |
Azaindole inhibitors of aurora kinases
|
CN101389630A
(zh)
|
2005-12-29 |
2009-03-18 |
艾博特公司 |
蛋白激酶抑制剂
|
EP1973532A1
(en)
|
2006-01-16 |
2008-10-01 |
Jubilant Organosys Limited |
Stable pharmaceutical formulation of an acid labile compound and process for preparing the same
|
WO2007087395A2
(en)
|
2006-01-25 |
2007-08-02 |
Osi Pharmaceuticals, Inc. |
UNSATURATED mTOR INHIBITORS
|
US7723330B2
(en)
|
2006-03-07 |
2010-05-25 |
Array Biopharma Inc. |
Heterobicyclic pyrazole compounds and methods of use
|
US7651687B2
(en)
|
2006-03-13 |
2010-01-26 |
Osi Pharmaceuticals, Inc. |
Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors
|
DE102006012301A1
(de)
|
2006-03-15 |
2007-09-20 |
Cemag-Anlagenbau-Dessau Gmbh |
Herstellung von Zementklinker
|
DK2004683T3
(en)
|
2006-03-24 |
2016-08-22 |
Biogen Hemophilia Inc |
PC5 AS A FACTOR IX PROPEPTID PROCESSING ENZYM
|
EP2007373A4
(en)
|
2006-03-29 |
2012-12-19 |
Foldrx Pharmaceuticals Inc |
INHIBITION OF ALPHA SYNUCLEINE TOXICITY
|
US20080032960A1
(en)
|
2006-04-04 |
2008-02-07 |
Regents Of The University Of California |
PI3 kinase antagonists
|
DE102006020327A1
(de)
|
2006-04-27 |
2007-12-27 |
Bayer Healthcare Ag |
Heterocyclisch substituierte, anellierte Pyrazol-Derivate und ihre Verwendung
|
GB0610242D0
(en)
|
2006-05-23 |
2006-07-05 |
Novartis Ag |
Organic compounds
|
US20080004286A1
(en)
|
2006-06-30 |
2008-01-03 |
Schering Corporation |
Method of Using Substituted Piperidines that Increase P53 Activity
|
AU2007275634B2
(en)
|
2006-07-21 |
2011-01-20 |
Novartis Ag |
Formulations for benzimidazolyl pyridyl ethers
|
US7718648B2
(en)
|
2006-08-09 |
2010-05-18 |
Millennium Pharmaceuticals, Inc. |
Pyridobenzazepine compounds and methods for inhibiting mitotic progression
|
EP1900729A1
(en)
|
2006-09-15 |
2008-03-19 |
Novartis AG |
Benzoxazoles and oxazolopyridines being useful as Janus kinases inhibitors
|
WO2008054808A2
(en)
|
2006-10-31 |
2008-05-08 |
Achillion Pharmaceuticals, Inc. |
Elvucitabine pharmaceutical compositions
|
CL2007003244A1
(es)
*
|
2006-11-16 |
2008-04-04 |
Millennium Pharm Inc |
Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
|
WO2008083070A1
(en)
|
2006-12-29 |
2008-07-10 |
Neurogen Corporation |
Crf1 receptor ligands comprising fused bicyclic heteroaryl moieties
|
AR065802A1
(es)
|
2007-03-22 |
2009-07-01 |
Schering Corp |
Formulaciones de comprimidos que contienen sales de 8- [( 1- ( 3,5- bis- (trifluorometil) fenil) -etoxi ) - metil) -8- fenil -1, 7- diaza- spiro [ 4,5] decan -2- ona y comprimidos elaborados a partir de estas
|
PE20090596A1
(es)
|
2007-08-14 |
2009-06-07 |
Bayer Schering Pharma Ag |
Imidazoles biciclicos fusionados
|
AU2008321099A1
(en)
|
2007-11-13 |
2009-05-22 |
Icos Corporation |
Inhibitors of human phosphatidyl-inositol 3-kinase delta
|
US20090203671A1
(en)
|
2007-11-27 |
2009-08-13 |
Abbott Laboratories |
Method of treating cancer
|
NZ613219A
(en)
|
2008-01-04 |
2014-11-28 |
Intellikine Llc |
Heterocyclic containing entities, compositions and methods
|
JP5547099B2
(ja)
|
2008-03-14 |
2014-07-09 |
インテリカイン, エルエルシー |
キナーゼ阻害剤および使用方法
|
WO2009114874A2
(en)
|
2008-03-14 |
2009-09-17 |
Intellikine, Inc. |
Benzothiazole kinase inhibitors and methods of use
|
WO2009158687A1
(en)
|
2008-06-26 |
2009-12-30 |
Anterios, Inc. |
Dermal delivery
|
CN102124009B
(zh)
|
2008-07-08 |
2014-07-23 |
因特利凯公司 |
激酶抑制剂及其使用方法
|
US20110224223A1
(en)
|
2008-07-08 |
2011-09-15 |
The Regents Of The University Of California, A California Corporation |
MTOR Modulators and Uses Thereof
|
WO2010036380A1
(en)
|
2008-09-26 |
2010-04-01 |
Intellikine, Inc. |
Heterocyclic kinase inhibitors
|
US8476431B2
(en)
*
|
2008-11-03 |
2013-07-02 |
Itellikine LLC |
Benzoxazole kinase inhibitors and methods of use
|
WO2010074724A1
(en)
*
|
2008-12-22 |
2010-07-01 |
Millennium Pharmaceuticals, Inc. |
Combination of aurora kinase inhibitors and anti-cd20 antibodies
|
EP2427195B1
(en)
|
2009-05-07 |
2019-05-01 |
Intellikine, LLC |
Heterocyclic compounds and uses thereof
|
JO3635B1
(ar)
|
2009-05-18 |
2020-08-27 |
Millennium Pharm Inc |
مركبات صيدلانية صلبة وطرق لانتاجها
|
WO2010144468A1
(en)
*
|
2009-06-10 |
2010-12-16 |
Abbott Laboratories |
2- ( lh-pyrazol-4 -ylamino ) -pyrimidine as kinase inhibitors
|
JO3434B1
(ar)
|
2009-07-31 |
2019-10-20 |
Millennium Pharm Inc |
مركبات صيدلانية لمعالجة السرطان وامراض واضطرابات اخري
|
ES2432315T3
(es)
|
2009-08-28 |
2013-12-02 |
Takeda Pharmaceutical Company Limited |
Compuestos de hexahidrooxazinopterina para su uso como inhibidores de mTOR
|
CA2788774A1
(en)
|
2010-02-19 |
2011-08-25 |
Millennium Pharmaceuticals, Inc. |
Crystalline forms of sodium 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5h-pyrimido[5,4-d][2]benzazepin-2-yl]amino}-2-methoxybenzoate
|
WO2012006589A2
(en)
|
2010-07-08 |
2012-01-12 |
Infinity Pharmaceuticals, Inc. |
Methods and compositions for identification, assessment and treatment of cancers associated with hedgehog signaling
|
EP2705181B1
(en)
*
|
2011-05-04 |
2016-12-21 |
Intellikine, LLC |
Combination pharmaceutical compositions and uses thereof
|